Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
5
5 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- siRNAADX-038, ADX-324Phase 37 trials
ADARx Pharmaceuticals, Inc. · Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1
- DeucrictibantPHVS416, PHA121Phase 35 trials
Pharvaris Netherlands B.V. · Hereditary Angioedema (HAE), Hereditary Angioedema, Hereditary Angioedema Type I
- KVD900Phase 33 trials
KalVista Pharmaceuticals, Ltd. · Hereditary Angioedema
- NTLA-2002Phase 31 trial
Intellia Therapeutics · Hereditary Angioedema
- BW-20805Phase 21 trial
Shanghai Argo Biopharmaceutical Co., Ltd. · Hereditary Angioedema (HAE)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.